Steven C. Crouse - 17 Aug 2026 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship
President - Diag & Spatial Bi
Issuer ticker
TECH
Reported as of
17 Aug 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Aug 2026, 16:46:48 UTC
Prior SEC filing
18 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick as Attorney-in-Fact for Steven C. Crouse pursuant to Power of Attorney previously filed.

Key filing fact

Steven C. Crouse filed Form 4 for BIO-TECHNE Corp (TECH) on 19 Aug 2026.

Key facts

  • This page summarizes Steven C. Crouse's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 2 reported transactions and 17 derivative rows are listed below.
  • Accepted by SEC: 19 Aug 2026, 16:46.

Change

  • Previous filing in this sequence was filed on 18 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002065241 Primary reporting owner

Crouse Steven C.

Relationship
President - Diag & Spatial Bi
Address
614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature
/s/ Andrew Nick as Attorney-in-Fact for Steven C. Crouse pursuant to Power of Attorney previously filed.
Signature date
19 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,237
Date
17 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+8,702
Change %
Price
$0.000000*
Shares after
8,702
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,702
Exercise price
Footnotes
F8, F15
TECH transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+14,140
Change %
Price
$0.000000*
Shares after
14,140
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,140
Exercise price
Footnotes
F8, F16
TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,856
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,856
Exercise price
$97.13
Footnotes
F1
TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
19,032
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,032
Exercise price
$120.46
Footnotes
F1
TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
24,560
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,560
Exercise price
$94.52
Footnotes
F1
TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,649
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,649
Exercise price
$84.61
Footnotes
F2
TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,327
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,327
Exercise price
$73.46
Footnotes
F3
TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
17,133
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,133
Exercise price
$74.91
Footnotes
F4
TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,434
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,434
Exercise price
$48.61
Footnotes
F5
TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
19,151
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,151
Exercise price
$53.60
Footnotes
F6
TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,911
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,911
Exercise price
$57.82
Footnotes
F7
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,387
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,387
Exercise price
Footnotes
F8, F9
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
794
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
794
Exercise price
Footnotes
F8, F10
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,200
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,200
Exercise price
Footnotes
F8, F11
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,869
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,869
Exercise price
Footnotes
F8, F12
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,353
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,353
Exercise price
Footnotes
F8, F13
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
735
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
735
Exercise price
Footnotes
F8, F14
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 16 footnotes

Footnote F1

100% vested.

Footnote F2

Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025.

Footnote F3

Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027.

Footnote F4

Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026.

Footnote F5

Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029.

Footnote F6

Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028.

Footnote F7

Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029.

Footnote F8

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F9

Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F10

794 restricted stock units vest on 5/1/2027.

Footnote F11

600 restricted stock units vest on each of 6/2/2027 and 6/2/2028.

Footnote F12

1,869 restricted stock units vest on 8/15/2027.

Footnote F13

2,177 restricted stock units vest on 8/15/2027, and 2,176 restricted stock units vest on 8/15/2028.

Footnote F14

245 restricted stock units vest on each of 3/2/2027, 3/2/2028 and 3/2/2029.

Footnote F15

2,901 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 2,900 restricted stock units vest on 8/17/2029.

Footnote F16

14,140 restricted stock units vest on 8/17/2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .